[HTML][HTML] Current progress and mechanisms of bone metastasis in lung cancer: a narrative review
S Wu, Y Pan, Y Mao, Y Chen, Y He - Translational lung cancer …, 2021 - ncbi.nlm.nih.gov
Lung cancer is a kind of malignant tumor with rapid progression and poor prognosis. Distant
metastasis has been the main cause of mortality among lung cancer patients. Bone is one of …
metastasis has been the main cause of mortality among lung cancer patients. Bone is one of …
Combination of DNA demethylation and chemotherapy to trigger cell pyroptosis for inhalation treatment of lung cancer
Pyroptosis is an inflammation-dependent and self-cascade amplifying type of programmed
cell death, serving as an effective means for activating the local immune response and …
cell death, serving as an effective means for activating the local immune response and …
Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts
R Kato, K Haratani, H Hayashi, K Sakai, H Sakai… - British journal of …, 2021 - nature.com
Abstract Background Cancer-associated fibroblasts (CAFs) in the tumour microenvironment
(TME) suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has …
(TME) suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has …
Pulmonary targeting crosslinked cyclodextrin metal–organic frameworks for lung cancer therapy
Y He, T Xiong, S He, H Sun, C Huang… - Advanced Functional …, 2021 - Wiley Online Library
Lung cancer is a serious threat to human health with the highest morbidity and mortality;
metastatic lung cancer accounts for a majority of cancer‐related deaths. Hence, there is …
metastatic lung cancer accounts for a majority of cancer‐related deaths. Hence, there is …
[HTML][HTML] Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-/liposome-based nanovesicles
Y Yan, C Du, X Duan, X Yao, J Wan, Z Jiang… - … Pharmaceutica Sinica B, 2022 - Elsevier
The lung is one of the most common sites for cancer metastasis. Collagens in the lung
provide a permissive microenvironment that supports the colonization and outgrowth of …
provide a permissive microenvironment that supports the colonization and outgrowth of …
Targeting inflammation in non-small cell lung cancer through drug repurposing
Lung cancer is the most common cause of cancer-related deaths. Lung cancers can be
classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers …
classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers …
[HTML][HTML] Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study
XQ Zheng, JF Huang, JL Lin, L Chen… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
Background Bone is one of the common metastatic sites of lung cancer, and its prognosis is
not optimistic. We performed a study to evaluate the incidence, survival, and prognostic …
not optimistic. We performed a study to evaluate the incidence, survival, and prognostic …
Multicellular effects of STAT3 in non-small cell lung cancer: Mechanistic insights and therapeutic opportunities
Simple Summary Persistent activation of STAT3 is frequently observed in non-small cell lung
cancer and is associated with a poor prognosis. Given the multifaceted role of STAT3 …
cancer and is associated with a poor prognosis. Given the multifaceted role of STAT3 …
Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation
B Jiang, X Zhao, W Chen, W Diao, M Ding… - Nature …, 2022 - nature.com
Organotropism during cancer metastasis occurs frequently but the underlying mechanism
remains poorly understood. Here, we show that lysosomal protein transmembrane 5 …
remains poorly understood. Here, we show that lysosomal protein transmembrane 5 …
CT041 CAR T cell therapy for Claudin18. 2-positive metastatic pancreatic cancer
C Qi, T Xie, J Zhou, X Wang, J Gong, X Zhang… - Journal of Hematology & …, 2023 - Springer
Pancreatic cancer lacks effective therapy. Here, we reported two metastatic pancreatic
cancer patients administrated with Claudin 18.2 (CLDN 18.2) CART therapy after the failure …
cancer patients administrated with Claudin 18.2 (CLDN 18.2) CART therapy after the failure …